| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000021501 |
| Receipt No. | R000024797 |
| Official scientific title of the study | Clinical study of photodynamic therapy for peripheral typelung cancers |
| Date of disclosure of the study information | 2016/03/16 |
| Last modified on | 2018/03/18 (Ver. 3) |
| Basic information | ||
| Official scientific title of the study | Clinical study of photodynamic therapy for peripheral typelung cancers | |
| Title of the study (Brief title) | Clinical study of photodynamic therapy for peripheral typelung cancers | |
| Region |
|
|
| Condition | |||
| Condition | Lung Cancer | ||
| Classification by specialty |
|
||
| Classification by malignancy | Malignancy | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | To study the safety and efficacy of Photodynamic therapy for periferal lung cancer |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | frequency of adverse event of grade 2 or more within 90 days of PDT |
| Key secondary outcomes | Recurrence free survival rate at 90days and 1 year after PDT |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |||
| No. of arms | 1 | ||
| Purpose of intervention | Treatment | ||
| Type of intervention |
|
||
| Interventions/Control_1 | Photodynamic theapy | ||
| Interventions/Control_2 | |||
| Interventions/Control_3 | |||
| Interventions/Control_4 | |||
| Interventions/Control_5 | |||
| Interventions/Control_6 | |||
| Interventions/Control_7 | |||
| Interventions/Control_8 | |||
| Interventions/Control_9 | |||
| Interventions/Control_10 | |||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Cancer nodule within 20mm in maximum measured by thin-slice CT
Negative for lymphnode or distant metastasis measured by FDG-PET, abdomnal CT or US, Brain CT or MRI. ECOG PS 0-2 Over 20 years old Platete: 100000~400000 PT-INR: less than 1.4 Diagnosed as non-small cell lung cancer by trans-bronchal biopsy or cytology Inoperable case or Reject operation cases with written informed concent |
|||
| Key exclusion criteria | Patients with anti-coagulant dose, except for salicylic acid formulation in the past week
women who are/may pregnant, or lactating Patients with serious complications such as heart disease, liver disease and kidney failure Patients who have the porphyria Patients who have the sunlight hypersensitivity Patients who have been determined to be inappropriate as a subject upon the doctor's discretion |
|||
| Target sample size | 6 | |||
| Research contact person | |
| Name of lead principal investigator | Jitsuo Usuda |
| Organization | Nippon Medical School Hospital |
| Division name | Thoracic Surgery |
| Address | 1 Chome-1-5 Sendagi Bunkyo-ku, Tokyo |
| TEL | 03-3822-2131 |
| jusuda@nms.ac.jp | |
| Public contact | |
| Name of contact person | Jitsuo Usuda |
| Organization | Nippon Medical School Hospital |
| Division name | Thoracic Surgery |
| Address | 1 Chome-1-5 Sendagi Bunkyo-ku, Tokyo |
| TEL | 03-3822-2131 |
| Homepage URL | |
| jusuda@nms.ac.jp | |
| Sponsor | |
| Institute | Nippon Medical School Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Japan Agency for Medical Research and Development (AMED) |
| Organization | |
| Division | |
| Category of Funding Organization | Japanese Governmental office |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000024797 |